In addition, APL cells often do not express CD34 on the cell surface, but do often express atypical lymphoid linage markers (CD56, CD19, or CD2), again suggesting that PML-RARA may initiate disease (in human patients) within a multipotent progenitor compartment [15]. Here, CD34 is linked to acute promyelocytic leukemia.